Standard BioTools Inc. (LAB) Cash Flow Statement
Standard BioTools Inc. (LAB) generated -$80.3M of operating cash flow over the twelve months to 2026-06-30, spent $2.3M on capital expenditure and had free cash flow of -$82.6M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LABStandard BioTools Inc.Follow LAB — free
—
Price chart with a free account
- Market cap
- 237.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -17.5 | -17.5 | -1.6 | -22.6 | -34.7 | -39.1 | -24.1 | -25.2 | -35.2 | -15.4 | -44.1 | -89.4 | -43.3 | -143.5 | -74.3 | -80.3 | |
| Capital expenditure | 1.7 | 2.4 | 3.4 | 7.4 | 4.0 | 5.1 | 1.6 | 0.4 | 2.5 | 12.7 | 13.3 | 3.8 | 2.8 | 8.4 | 8.3 | -2.3 | |
| Free cash flow | -19.2 | -19.9 | -5.0 | -30.0 | -38.7 | -44.2 | -25.7 | -25.6 | -37.7 | -28.1 | -57.3 | -93.2 | -46.1 | -151.8 | -82.6 | -82.6 | |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | 0.6 | 5.4 | 40.5 | 0.0 | — | |
| Stock-based compensation | 2.8 | 4.1 | 6.4 | 20.9 | 16.8 | 13.9 | 9.1 | 11.0 | 11.4 | 14.5 | 16.1 | 14.9 | 13.1 | 31.7 | 29.6 | — |
USD millions · SEC XBRL
Standard BioTools Inc. — questions
- What is Standard BioTools Inc.'s operating cash flow?
- -$80.3M over the twelve months to 2026-06-30.
- How much does Standard BioTools Inc. spend on capital expenditure?
- $2.3M over the twelve months to 2026-06-30.
- What is Standard BioTools Inc.'s free cash flow?
- -$82.6M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Standard BioTools Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.